$Efficacy of oral amphotericin B for refractory atopic dermatitis with specific IgE to Candida albicans and food allergens in sera$

Efficacy of oral amphotericin B for refractory atopic dermatitis with specific IgE to Candida albicans and food allergens in sera

The efficacy of oral amphotericin B (ApB) was studied in 125 cases of refractory atopic dermatitis (AD). Indications for ApB therapy were positive CAP-RAST (Pharmacia & Upjohn Co. Ltd)-class to Candida albicans and several food allergens and a high intake of sweets or alcoholic beverages togethe...

Full description

Bibliographic Details
Main Authors:	Kazuko Kitamura, Chizuka Suga, Sumi Onuma, Toshiko Kawaguchi, Fusae Yamazaki, Hiroshi Suguro, Zenro Ikezawa
Format:	Article
Language:	English
Published:	Elsevier 1997-01-01
Series:	Allergology International
Subjects:	amphotericin B antifungal therapy atopic dermatitis Candida albicans food allergy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1323893015315896

Similar Items

Amphotericin
by: 982 SIRIM

Nicotinamide potentiates amphotericin B activity against Candida albicans
by: Yu Yan, et al.
Published: (2022-12-01)

Elevation of the resistance of heat-cured acrylic denture base resin against biofilm-forming Candida albicans by incorporating Amphotericin B or Clotrimazole
by: Ali Abdul Hussein S. AL-Janabi, et al.
Published: (2018-01-01)

The synergistic effects of hydroxychavicol and amphotericin B towards yeast-hyphae transition and the germination of Candida albicans
by: Wan H.A.W. Harun, PhD, et al.
Published: (2023-10-01)

Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review
by: Lucas Soares Bezerra, et al.
Published: (2020-05-01)

Enhancing the Antibiofilm Activity of β-1,3-Glucanase-Functionalized Nanoparticles Loaded With Amphotericin B Against Candida albicans Biofilm
by: Yulong Tan, et al.
Published: (2022-05-01)

The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus
by: Moufid El-Khoury, et al.
Published: (2017-08-01)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
by: Anthony Anderson, et al.
Published: (2017-09-01)

REFRACTORY FUNGAL VAGINITIS TREATED BY TOPICAL AMPHOTERICIN B. Review
by: Falah Hasan Obayes AL-Khikani
Published: (2020-06-01)

The Antifungal Effect of Silver, Copper Nanoparticles, and Their Combination and in combination with Amphotericin B against Candida albicans In Vitro and in Animal Model
by: Hossein Soltani, et al.
Published: (2018-02-01)

Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01)

THE EFFECT OF FLUCONAZOLE AND AMPHOTERICIN B ON MACROPHAGE FUNCTIONS
by: Glazar Irena, et al.
Published: (2015-12-01)

Liposomal amphotericin B and leishmaniasis: Dose and response
by: Shyam Sundar, et al.
Published: (2010-01-01)

<it>In vitro </it>cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against <it>Candida albicans</it>, human monocytic and kidney cell lines
by: Clement John G, et al.
Published: (2011-08-01)

Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine
by: Line Storm, et al.
Published: (2014-10-01)

Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
by: Maria Aigner, et al.
Published: (2020-05-01)

Methods for particle size reduction of liposomal amphotericin B
by: Tuan Quang Nguyen, et al.
Published: (2018-03-01)

Amphotericin B and Curcumin Co-Loaded Porous Microparticles as a Sustained Release System against <i>Candida albicans</i>
by: Baiji Xue, et al.
Published: (2022-05-01)

Amphotericin B induced pancytopenia
by: Esha Vaish, et al.
Published: (2022-01-01)

Effect of Amphotericin B and Fluconazole on hospital wards fungi
by: Nowrozi H, et al.
Published: (2014-10-01)

Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis
by: Vahid Mashayekhi Goyonlo, et al.
Published: (2014-01-01)

Anecdotal Response to Amphotericin in a Patient with Probable Susac Syndrome: Implications in the Pathogenesis
by: Raquel Gil-Gouveia, et al.
Published: (2019-11-01)

Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
by: R. Lu, et al.
Published: (2019-06-01)

Standart and Lipozomal Amphotericin B in Febrile Neutropenia with Hematological Malignancies
by: H. Şenol COŞKUN, et al.
Published: (1998-06-01)

Pentoxifylline in prevention of amphotericin B-induced nephrotoxicity and electrolyte abnormalities
by: Mahsa Panahi-Shokouh, et al.
Published: (2020-01-01)

MRSA bacteraemia complicating amphotericin B treatment of cryptococcal meningitis
by: J Scriven, et al.
Published: (2013-09-01)

Intralipid efficacy in decreasing Amphotericin B associated nephrotoxicity
by: Hasibi M, et al.
Published: (2013-03-01)

The Role of Retrobulbar Injection of Amphotericin B in the Management of Orbital Mucormycosis in a Tertiary Care Centre—Prospective Analytical Study
by: A Yogeswari, et al.
Published: (2023-01-01)

Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans
by: Zhou L, et al.
Published: (2017-06-01)

Cyanotic Raynaud's phenomenon induced by amphotericin B deoxycholate: A case report
by: Nayla A. Hatem, et al.
Published: (2023-09-01)

Rhino–Orbito–Cerebral Mucormycosis Resistant to Amphotericin B: Two Diabetic Cases
by: Esma Eren, et al.
Published: (2019-09-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-05-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-02-01)

In vitro activity of amphotericin B cochleates against Leishmania chagasi
by: Aretha Molina Sesana, et al.
Published: (2011-03-01)

Successful treatment of cutaneous protothecosis with liposomal amphotericin and oral itraconazole
by: Brendan McMullan, et al.
Published: (2016-06-01)

Amphotericin B-related nephrotoxicity in low-risk patients
by: Roberto Herz Berdichevski, et al.

A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis
by: Luis Valda Rodriguez, et al.
Published: (1995-08-01)

Clinico-pathological correlation and outcome analysis of disseminated histoplasmosis treated with conventional amphotericin B.
by: D. Modak, et al.
Published: (2015-10-01)